Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 111-120 of 146

Page
per page
  1. CITCO
    B7468 CITCO
     1 Citation
    Target: constitutive androstane receptor (CAR)
    Summary: A selective constitutive androstane receptor (CAR) agonist
      Soluble in DMSO
  2. DLPC
    B7661 DLPC
    Target: Nuclear Receptors
    Summary: LRH-1 agonist ligand
      ≥26.9 mg/mL
  3. GLP-2 (rat)
    B5282 GLP-2 (rat)
    Target: GLP-2 receptor
    Summary: intestinal epithelium-specific growth factor
      ≥138.05 mg/mL
  4. Ro 106-9920
    B6853 Ro 106-9920
    Summary: Inhibitor of NF-κB activation
      ≥24.5 mg/mL
  5. Iberiotoxin
    B6591 Iberiotoxin
    Summary: blocker of the big conductance Ca2+-activated K+ channel
      Soluble in H2O
  6. A23187, free acid
    B6646 A23187, free acid
    Summary: Ca2+ ionophore
      Soluble in DMSO
  7. GnRH Associated Peptide (GAP) (1-13), human
    A1020 GnRH Associated Peptide (GAP) (1-13), human
    Target: prolactin secretion|gonadotropin release
    Summary: Inhibitor of prolactin secretion
      insoluble in H2O; insoluble in EtOH; ≥74.6 mg/mL
  8. Imiquimod
    A5161 Imiquimod
    Target: Toll-like receptors (TLRs)
    Summary: TLR-7 agonist,immunomodulator with antiviral and antitumor activity
      insoluble in H2O; insoluble in EtOH; ≥1.2 mg/mL
  9. Varespladib (LY315920)
    A4356 Varespladib (LY315920)
    Target: Phospholipases
    Summary: HnsPLA inhibitor,potent and selective
  10. ME0328
    A8808 ME0328
    Target: PARP
    Summary: PARP inhibitor,potent and selective
      ≥71.43 mg/mL

Items 111-120 of 146

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 136item
  2. Natural Products 3item
  3. Kits 1 item
  4. Lab Reagents 5item
Specificity
  1. Selective 84item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 5item
  2. Irreversible 2item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 4item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 7item
  5. PI3K 5item
  6. Raf 4item
  7. CSF-1R 1 item
  8. Peptidylprolyl isomerases 1 item
  9. FLT3 2item
  10. GSK-3 2item
  11. Factor Xa 1 item
  12. PLK 1 item
  13. VEGFR 6item
  14. PDGFR 4item
  15. c-Kit 2item
  16. RET 1 item
  17. Thymidylate Synthase 1 item
  18. p38 2item
  19. MEK 1 item
  20. FGFR 2item
  21. Nrf2 1 item
  22. Voltage-gated Sodium (NaV) Channels 1 item
  23. Deubiquitinating enzymes (DUBs) 2item
  24. PP1 1 item
  25. PP2A 1 item
  26. MET 2item
  27. Src 1 item
  28. Trk Receptors 1 item
  29. NMDA Receptors 1 item
  30. STAT 1 item
  31. EGFR 2item
  32. Reverse Transcriptases 1 item
  33. ROCK 1 item
  34. JAK 1 item
  35. Topoisomerases 5item
  36. Cytochrome P450 (CYP450) 1 item
  37. Toll-like receptors (TLRs) 1 item
  38. HMG-CoA Reductases 1 item
  39. c-MET 3item
  40. PKC 2item
  41. Protease-Activated Receptors 1 item
  42. HER2 1 item
  43. 5-HT2 Receptors 1 item
  44. DGAT 1 item
  45. Insulin and Insulin-like Receptors 1 item
  46. PARP 2item
  47. CB1 Receptors 1 item
  48. ALK 3item
  49. PKG 1 item
  50. PKA 1 item
  51. Myosin light chain kinases (MLCKs) 2item
  52. D2 Receptors 1 item
  53. 5-HT1 Receptors 1 item
  54. 5-HT7 Receptors 1 item
  55. 5-HT3 Receptors 1 item
  56. Angiotensin-Converting Enzymes (ACEs) 1 item
  57. Autophagy 1 item
  58. COX 4item
  59. Pregnane X Receptors 1 item
  60. Squalene epoxidases 1 item
  61. GpIIb/IIIa receptor 1 item
  62. Peroxynitrite 1 item
  63. P2X Receptors 1 item
  64. Ron 1 item
  65. Synthases/Synthetases 1 item
  66. Histamine H1 Receptors 1 item
  67. Phospholipases 1 item
  68. IL Receptors 1 item
  69. CCL2 1 item
  70. Noradrenaline reuptake 1 item
  71. Calcium-Activated Potassium (KCa) Channels 1 item
  72. AChE 1 item
  73. cAMP 1 item
  74. Sulfonylurea receptors 1 item
  75. Peptidoglycan synthesis 1 item
  76. Nuclear Receptors 1 item
  77. Catechol O-Methyltransferase (COMT) 1 item
  78. Angiotensin AT1 Receptors 1 item
  79. Hydroxylases 1 item
  80. DREADD Ligands 1 item
  81. PP4 1 item
  82. AChR 1 item
  83. sodium channels 1 item
  84. Fyn kinase 1 item
  85. KDM 1 item
  86. Ub-conjugating enzyme (E2) complex 1 item
  87. Nrf2/ARE signal 1 item
  88. PPAR 3item
  89. IKK 1 item
  90. PC-PLC 1 item
  91. P97 ATPase 1 item
  92. Antibiotic 1 item
  93. Hec1 1 item
  94. Calmodulins 1 item
  95. ErbB-2 1 item
  96. adrenergic receptor 1 item
  97. TRPA 1 item
  98. Histone Acetyltransferases (HATs) 1 item
  99. constitutive androstane receptor (CAR) 1 item
  100. Tyrosinases 1 item
  101. ITK 1 item
  102. NUAK 1 item
  103. SERT 1 item
  104. prolactin secretion 1 item
  105. gonadotropin release 1 item
  106. 5-HT receptor 1 item
  107. 5-alpha Reductases 1 item
  108. NOP Receptors 1 item
  109. Transferases 1 item
  110. Dopamine receptor 1 item
  111. Histamine receptor 1 item
  112. DHFR 1 item
  113. GARFT 1 item
  114. Octamer-binding transcription factor 4 (Oct4) 1 item
  115. GLP-2 receptor 1 item
  116. PRMT 1 item
  117. epoxide hydrolase 1 item
  118. Serotonin (5-HT) reuptake 1 item
  119. NE 1 item
  120. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Anesthesia 1 item
  4. Bladder Cancer 1 item
  5. B-lymphoid Malignancies 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 9item
  8. Cancer 55item
  9. Chronic Lymphocytic Leukemia 2item
  10. Cocaine-Related Disorders 1 item
  11. Colon Cancer 4item
  12. Colorectal Cancer 7item
  13. Depression 1 item
  14. Diabetes 3item
  15. Glioblastoma 4item
  16. Glioma 2item
  17. Hepatocellular Carcinoma 1 item
  18. HIV 1 item
  19. Inflammatory Diseases 2item
  20. Lung Cancer 1 item
  21. Lung Carcinoma 1 item
  22. Lymphoma 5item
  23. Mantle Cell Lymphoma 2item
  24. Melanoma 3item
  25. Multiple Myeloma 4item
  26. Myeloma 1 item
  27. Neuroblastoma 3item
  28. Neurocognitive Disorders 1 item
  29. Non-small Cell Lung Cancer 3item
  30. Obsessive-Compulsive Disorder 1 item
  31. Ovarian Cancer 3item
  32. Pancreatic Cancer 3item
  33. Prostate Cancer 3item
  34. Renal Cancer 1 item
  35. Rheumatoid Arthritis 1 item
  36. Schizophrenia 2item
  37. Thyroid Cancer 1 item
  38. Type 2 Diabetes 2item